We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

News   May 16, 2018 | Original story from University of Arizona

 
Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

The inactive form (left) of the MAPK p38 enzyme moves in an uncoordinated fashion. Once the necessary molecules (blue blob and P symbols) bind, the enzyme becomes active (right) by moving in a coordinated fashion to do its job inside a cell. Credit: Senthil Ganesan, University of Arizona Department of Chemistry and Biochemistry.

 
 
 

RELATED ARTICLES

Compound Combo Shrinks Pancreatic Tumors in Mice Providing Rationale for Clinical Study

News

Scientists have identified a combination of two anti-cancer compounds that were able to shrink pancreatic tumors in mice – supporting the immediate evaluation of the drugs in a clinical trial.

READ MORE

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE